Accession | Title | Sample type | Organism(s) | Ch | Platform | Series | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|---|
![]() |
![]() |
![]() |
|||||||
GSM6428697 |
All samples
|
SRA | 1 | Tatsuya Tsukui | Apr 18, 2024 | ||||
GSM8087356 |
Antibody_1 treated
|
SRA | 1 | Jesse W Williams | Apr 18, 2024 | ||||
GSM8087357 |
Antibody_2 treated
|
SRA | 1 | Jesse W Williams | Apr 18, 2024 | ||||
GSM8208487 |
BM-Muse#1
|
SRA | 1 | Yoshihiro Kushida | Apr 18, 2024 | ||||
GSM8208488 |
BM-Muse#2
|
SRA | 1 | Yoshihiro Kushida | Apr 18, 2024 | ||||
GSM8208489 |
BM-Muse#3
|
SRA | 1 | Yoshihiro Kushida | Apr 18, 2024 | ||||
GSM7230165 |
BV2 cells, Control+vehicle [C1]
|
SRA | 1 | Yamei Tang | Apr 18, 2024 | ||||
GSM7230166 |
BV2 cells, Control+vehicle [C2]
|
SRA | 1 | Yamei Tang | Apr 18, 2024 | ||||
GSM7230167 |
BV2 cells, Control+vehicle [C3]
|
SRA | 1 | Yamei Tang | Apr 18, 2024 | ||||
GSM7230171 |
BV2 cells, Radiation+5α-androst-3β, 5α, 6β-triol [Y1]
|
SRA | 1 | Yamei Tang | Apr 18, 2024 | ||||
GSM7230172 |
BV2 cells, Radiation+5α-androst-3β, 5α, 6β-triol [Y2]
|
SRA | 1 | Yamei Tang | Apr 18, 2024 | ||||
GSM7230173 |
BV2 cells, Radiation+5α-androst-3β, 5α, 6β-triol [Y3]
|
SRA | 1 | Yamei Tang | Apr 18, 2024 | ||||
GSM7230168 |
BV2 cells, Radiation+vehicle [R1]
|
SRA | 1 | Yamei Tang | Apr 18, 2024 | ||||
GSM7230169 |
BV2 cells, Radiation+vehicle [R2]
|
SRA | 1 | Yamei Tang | Apr 18, 2024 | ||||
GSM7230170 |
BV2 cells, Radiation+vehicle [R3]
|
SRA | 1 | Yamei Tang | Apr 18, 2024 | ||||
GSM8163690 |
C666-1 cells, KLF5, ChIP
|
SRA | 1 | zhenyu yang | Apr 18, 2024 | ||||
GSM8163691 |
C666-1 cells, input
|
SRA | 1 | zhenyu yang | Apr 18, 2024 | ||||
GSM7765986 |
CD45+ cells of Vector control overexpression tumor
|
SRA | 1 | Hanqiu Zheng | Apr 18, 2024 | ||||
GSM7765988 |
CD45+ cells of paracaspase-deficient Malt1 overexpression tumor
|
SRA | 1 | Hanqiu Zheng | Apr 18, 2024 | ||||
GSM7765987 |
CD45+ cells of wildtype Malt1 overexpression tumor
|
SRA | 1 | Hanqiu Zheng | Apr 18, 2024 |